Abstract
A quantitative method was developed and validated to assess bioburden on tissue from human donors and to compare bioburden determination results to swab culture results from the same donor. An initial study with allograft tissue from 101 donors showed a wide range of bioburden levels; values from no colony-forming units (CFU) detected to >28,000 CFU were observed. Tissues from donors that had swab cultures negative for objectionable microorganisms generally had lower bioburden than tissues from donors where objectionable microorganisms were recovered by swab culturing. In a follow-up study with 1,445 donors, a wide range of bioburden levels was again observed on tissues from donors that were swab culture negative for objectionable microorganisms. Tissues from 885 (61%) of these donors had no recoverable bioburden (<2 CFU). Importantly, tissues from 560 (39%) of the donors had recoverable bioburden which ranged from 1 to >24,000 CFU. Identification of bioburden isolates showed a diversity of genera and species. In compliance with the recent revision of the American Association of Tissue Banks K2.210 Standard, the quantitative bioburden determination method was validated with a composite tissue sample that contains bone and soft tissue sections tested together in one extraction vessel. A recovery efficiency of 68% was validated and the composite sample was shown to be representative of all of the tissues recovered from a donor. The use of the composite sample in conjunction with the quantitative bioburden determination method will facilitate an accurate assessment of the numbers and types of contaminating microorganisms on allografts prior to disinfection/sterilization. This information will ensure that disinfection/sterilization processes are properly validated and the capability of the overall allograft process is understood on a donor by donor basis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Dennis JA, Martinez OV, Landy DC, Malinin TI, Morris PR, Fox WP, Buck BE, Temple HT (2011) A comparison of two microbial detection methods used in aseptic processing of musculoskeletal allograft tissues. Cell Tissue Bank 12:45–50
Forsell JH, Liesman J (2000) Analysis of potential causes of positive microbiological cultures in tissue donors. Cell Tissue Bank 1:111–115
Journeaux SF, Johnson N, Bryce SL, Friedman SJ, Sommerville SMM, Morgan DAF (1999) Bacterial contamination rates during bone allograft retrieval. J Arthroplasty 14:677–681
Kowalski JB, Mosley GA, Merritt K, Osborne J (2011) Assessment of bioburden on human and animal tissues: Part 1—results of method development and validation studies. Cell Tissue Bank Online First. doi:10.1007/s10561-010-9238-9
Malinin TI, Buck BE, Temple HT, Martinez OV, Fox WP (2003) Incidence of clostridial contamination in donors’ musculoskeletal tissue. J Bone Joint Surg Br 85:1051–1054
Ronholdt CJ, Bogdansky S (2005) The appropriateness of swab cultures for the release of human allograft tissue. J Ind Microbiol Biotechnol 32:349–354
Sommerville SMM, Johnson N, Bryce SL, Journeaux SF, Morgan DAF (2000) Contamination of banked femoral head allograft: incidence, bacteriology and donor follow up. Aust NZ J Surg 70:480–484
Varettas K, Taylor P (2011) Bioburden assessment of banked bone used for allografts. Cell Tissue Bank 12:37–43
Veen MR, Bloem RM, Petit PL (1994) Sensitivity and negative predictive value of swab cultures in musculoskeletal allograft procurement. Clin Orthop Relat Res 300:259–263
Vehmeyer SB, Bloem RM, Petit PL (2001) Microbiological screening of post-mortem bone donors—two case reports. J Hosp Infect 47:193–197
Vehmeyer SB, Wolkenfelt J, Deijkers R, Petit P, Brand R, Bloem R (2002a) Bacterial contamination in postmortem bone donors. Acta OrthopScand 73:678–683
Vehmeyer SB, Sloof AR, Bloem RM, Petit PL (2002b) Bacterial contamination of femoral head allografts from living donors. Acta Orthop Scand 73:165–169
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kowalski, J.B., Merritt, K., Gocke, D. et al. Assessment of bioburden on human and animal tissues: Part 2—Results of testing of human tissue and qualification of a composite sample for routine bioburden determination. Cell Tissue Bank 13, 431–439 (2012). https://doi.org/10.1007/s10561-012-9296-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10561-012-9296-2